Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) FCF Margin (2021 - 2023)

Senti Biosciences has reported FCF Margin over the past 3 years, most recently at 1540.24% for Q3 2023.

  • Quarterly results put FCF Margin at 1540.24% for Q3 2023, down 100429.0% from a year ago — trailing twelve months through Jun 2024 was 9555.33% (down 791838.0% YoY), and the annual figure for FY2025 was 198363.64%, changed.
  • FCF Margin for Q3 2023 was 1540.24% at Senti Biosciences, up from 2779.18% in the prior quarter.
  • Over the last five years, FCF Margin for SNTI hit a ceiling of 120.14% in Q2 2021 and a floor of 16608.47% in Q4 2022.
  • Median FCF Margin over the past 3 years was 1465.05% (2023), compared with a mean of 2706.98%.
  • Biggest five-year swings in FCF Margin: plummeted -1521861bps in 2022 and later crashed -5817bps in 2023.
  • Senti Biosciences' FCF Margin stood at 1389.86% in 2021, then tumbled by -1095bps to 16608.47% in 2022, then skyrocketed by 91bps to 1540.24% in 2023.
  • The last three reported values for FCF Margin were 1540.24% (Q3 2023), 2779.18% (Q2 2023), and 1637.79% (Q1 2023) per Business Quant data.